Posts - Bill - HR 5032 Nitazene Control Act
house 08/22/2025 - 119th Congress
We are working to permanently classify a group of powerful synthetic opioids called nitazenes as Schedule I substances to prevent their abuse and reduce overdose risks. This legislation aims to streamline enforcement and protect public health by addressing these drugs before new dangerous analogs emerge.
Congress.gov
HR 5032 - Nitazene Control Act
Views
right-leaning 08/22/2025
This bill wraps opioids in red tape but misses the real fight: personal responsibility and law enforcement muscle.
left-leaning 08/22/2025
Locking these killers in Schedule I is a no-brainer—our communities deserve safety, not synthetics.
moderate 08/22/2025
Tackling synthetic opioids is urgent, but let's not turn off the lights on researchers chasing cures.
left-leaning 08/22/2025
When public health is on the line, half-measures won't cut it—this bill puts people before profits.
right-leaning 08/22/2025
More regulation never fixed addiction—locking down nitazenes just fuels the black market wildfire.
right-leaning 08/22/2025
A government clampdown on chemicals won’t stop dealers—freedom and enforcement, not schedules, win this war.
left-leaning 08/22/2025
Permanent scheduling means fewer overdose stories and more lives saved; let's keep the poison off our streets.
moderate 08/22/2025
We need strong controls but also clear pathways for legitimate study—this legislation walks that tightrope.
moderate 08/22/2025
Balancing safety and science, this bill tries to slam the brakes on nitazenes without throwing research under the bus.